Hannah Choe, Md

This study tests a new combination of three drugs (cyclophosphamide, tacrolimus, and ruxolitinib) to prevent graft-versus-host disease (GVHD) in people receiving a stem cell transplant for blood cancers like leukemia. The goal is to see if this approach can reduce severe GVHD and…